Qhslab Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Qhslab Inc 's ROA in the second quarter of 2026?
Qhslab Inc achieved a return on average assets (ROA) of 26.36 % in its second quarter of 2026, this is above USAQ's average return on assets of -464.22%.
Qhslab Inc assets over the 12 months ending in its second quarter of 2026 are valued at $2 million

ROA has improved compared to 23.09% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 36 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 184, from total ROA ranking in the first quarter of 2026 at 187.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	26.21 %	13.26 %	20.64 %	-1.7 %	0.7 %
Y / Y Net Income Change	-	-	-	-32.86 %	-
Net Income (TTM) in million	1	0	0	0	0
Return On Assets (TTM)	26.36 %	23.09 %	25.12 %	-17.78 %	-16.76 %
USAQ's Total Ranking	# 184	# 187	# 3498	# 3498	# 3466
Total Assets (TTM) in million	2	2	2	2	2
Seq. Total Assets Change	14.25 %	-12.99 %	25.16 %	1.44 %	2.53 %
Seq. Net Income Change	-	-	1565.84 %	-	-

USAQ's 5 Years Annual ROA >> Back to USAQ Management Effectiveness >> Compare USAQ ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 6
Sector	# 37
Overall	# 145

Return On Assets Statistics
High	Average	Low
27.12 %	-464.22 %	-3440.81 %
(Jun 30 2026)		(Jun 30 2020)

Financial Statements
Qhslab Inc 's Assets	$ 2 million	USAQ's Balance sheet
Qhslab Inc 's Income	$ 0 million	Quarterly USAQ's Income Statement
USAQ's Income by Division		See USAQ's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	20.64 %	7.02 %	-14.1 %	-11.37 %	641.45 %
Total Assets in million	2	2	2	2	2
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	0	0	0	-1	-1
Annual Return On Assets	21.07 %	-14.41 %	-27.85 %	-50.88 %	-34.87 %

USAQ's 5 Years Annual ROA >> Back to USAQ Management Effectiveness >> Compare USAQ ROA to its Competitors

Comment on USAQ's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 21.07 % compared to prior year, due to annual net income growth of % to $0.46 million, while value of Qhslab Inc 's overall assets grew just by 20.64 % to $2.17 million, compared to $2.17 a year before.

More Return On Assets Ratios
USAQ's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
USAQ's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for USAQ's Competitors
Subscribers only: Roa for Qhslab Inc 's Suppliers
Subscribers only: Return On Assets for USAQ's Customers

You may also want to know
USAQ's Roi	USAQ's Inventory Turnover Ratio	USAQ's Growth Rates	USAQ's Dividend Comparisons
	USAQ's Profitability Ratios	USAQ's Asset Turnover Ratio	USAQ's Dividend Growth
USAQ's Roe	USAQ's Valuation Ratios	USAQ's Financial Strength Ratios	USAQ's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Rigel Pharmaceuticals Inc	72.27 %
Actinium Pharmaceuticals Inc	71.73 %
Sanuwave Health Inc	71.60 %
Exelixis Inc	70.51 %
Rallybio Corporation	64.51 %
Oramed Pharmaceuticals Inc	64.18 %
Fortress Biotech Inc	60.88 %
Atlantic Coastal Acquisition Corp Ii	54.09 %
Lensar Inc	47.48 %
Elite Pharmaceuticals Inc	46.11 %
Omeros Corporation	46.05 %
Q32 Bio Inc	45.18 %
Aurinia Pharmaceuticals Inc	44.95 %
Agenus Inc	44.86 %
Earth Science Tech Inc	44.02 %
Liquidia Corporation	36.30 %
Ironwood Pharmaceuticals inc	34.34 %
Idexx Laboratories Inc	33.61 %
Tg Therapeutics Inc	33.59 %
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %

Date modified: 2026-09-04T00:13:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.